FIELD: medicine.
SUBSTANCE: invention involves a highly effective midkine aptamer and a pharmaceutical agent containing it.
EFFECT: aptamer enables inhibiting midkine activity and treating the related diseases.
10 cl, 12 dwg, 5 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APTAMER AGAINST NGF AND ITS APPLICATION | 2012 |
|
RU2633510C2 |
| APTAMER FOR FGF2 AND USE THEREOF | 2015 |
|
RU2686992C2 |
| APTAMER FOR CHYMASE, AND ITS USE | 2010 |
|
RU2579667C2 |
| APTAMERS ON BASIS OF DNA FOR HUMAN CATHEPSINE G | 2004 |
|
RU2360000C2 |
| MODIFIERS OF GLYCOPROTEIN VI REPRESENTING NUCLEIC ACID | 2010 |
|
RU2571660C2 |
| NUCLEIC ACID COMPOUNDS FOR BINDING GROWTH DIFFERENTIATION FACTOR 11 | 2015 |
|
RU2708170C2 |
| APTAMER PASSING THROUGH MOUSE BLOOD-BRAIN BARRIER OF MOUSE BRAIN | 2016 |
|
RU2711912C2 |
| COMPLEMENT-BINDING APTAMERS AND C5 AGENTS APPLICABLE FOR TREATING OCULAR DISORDERS | 2007 |
|
RU2477137C2 |
| APTAMERIC THERAPEUTIC AGENTS APPLICABLE FOR TREATING COMPLEMENT-RELATED DISORDERS | 2006 |
|
RU2406507C2 |
| METHOD TO SEPARATE SPERMATOZOA AND APPLIED COMPOSITIONS, CONTAINING APTAMERS OR SEQUENCES OF NUCLEIC ACIDS | 2007 |
|
RU2475539C2 |
